AlahlafiAMWordsworthPLakasingL. The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion. Lupus2004; 13: 594–600.
2.
AmitalHHeilweilMUlmanskyR. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol2005; 175: 5516–5523.
3.
AmitalHHeilweil-HarelMUlmanskyR. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford)2007; 46: 1433–1437.
GrothSReckeAVafiaK. Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol2011; 164: 76–82.
6.
SchmidtEZillikensD. Diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Ärztebl Int2011; 108: 399–405.
7.
DainichiTKuronoSOhyamaB. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A2009; 106: 2800–2805.
8.
VafiaKGrothSBeckmannT. Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One2012; 7: e41769–e41769.
9.
Mitate E, Kawano S, Nakao Y, et al. Concurrence of autoantibodies to both laminin gamma1 and gamma2 subunits in a patient with kidney rejection response. Acta Derm Venereol Epub ahead of print 27 June 2012. DOI: 10.2340/00015555-1395.
10.
Ben-YehudaARasoolyLBar-TanaR. The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun1995; 8: 279–291.
